Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2,31%
1 041,53
-24,68
-2,31%
—1 066,211 064,941 064,941 038,77——
SIXC
Communications
SIXC
Communications
SIXC
-0,97%
605,26
-5,90
-0,97%
—611,16611,16612,25604,78——
SIXE
Energy
SIXE
Energy
SIXE
+1,01%
1 282,74
+12,81
+1,01%
—1 269,931 273,161 287,581 262,69——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 700,27
-20,14
-1,17%
—1 720,411 717,391 717,391 694,47——
SIXM
Financials
SIXM
Financials
SIXM
-1,23%
629,31
-7,82
-1,23%
—637,13637,40637,74628,83——
SIXR
Staples
SIXR
Staples
SIXR
+0,18%
867,83
+1,58
+0,18%
—866,25865,77874,12858,72——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,43%
215,57
+0,93
+0,43%
—214,64214,64216,08213,49——
SIXT
Technology
SIXT
Technology
SIXT
-0,66%
3 487,87
-23,26
-0,66%
—3 511,133 481,073 527,593 440,20——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,99%
895,72
+8,80
+0,99%
—886,92885,23896,83881,74——
SIXV
Health care
SIXV
Health care
SIXV
+1,09%
1 486,47
+15,98
+1,09%
—1 470,491 470,681 494,421 462,16——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1,12%
2 323,57
-26,20
-1,12%
—2 349,772 332,172 332,172 307,43——
REPCF:OTCMKTS
RepliCel Life Sciences Inc
0,00010 $
0,00%
(0,00) 1D
6 ապր, 12:04:36 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REPCF...
Mkt. cap
7,36 հզր
Volume
0,00
52-wk high
0,00 $
52-wk low
0,00 $
EPS
-0,08 $
Shares outstanding
70,01 մլն
No. of employees
1
News stories
From sources across the web
Profile
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle. The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. Wikipedia
About RepliCel Life Sciences Inc
CEO-
Employees1
Founded1967
HeadquartersՎանքուվեր, Բրիտանական Կոլումբիա, Կանադա
Sector-
Websitereplicel.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
43,80 հզր
-
2,31 հզր
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99,71 հզր
21,72 հզր
5,25 հզր
-
Operating expense
143,51 հզր
21,72 հզր
7,56 հզր
-
Total operating expenses
143,51 հզր
21,72 հզր
7,56 հզր
-
Operating income
-143,51 հզր
-21,72 հզր
-7,56 հզր
-
Other non operating income
3,47 մլն
-
-
-
EBT including unusual items
-8,22 մլն
-28,65 հզր
-25,10 հզր
-
EBT excluding unusual items
3,32 մլն
-28,65 հզր
-25,10 հզր
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,22 մլն
-28,65 հզր
-25,10 հզր
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-6,93 հզր
-17,54 հզր
-
Net interest expenses
-
-6,93 հզր
-17,54 հզր
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-143,37 հզր
-21,58 հզր
-7,42 հզր
-
Gain or loss from assets sale
11,58 մլն
1,65 հզր
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer